Deli Zeng

Title: Deli Zeng: Innovator in Pharmaceutical Chemistry

Introduction

Deli Zeng is a notable inventor based in Suzhou, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of methods for synthesizing important drug intermediates. His work is characterized by a focus on efficiency and industrial applicability.

Latest Patents

Deli Zeng holds a patent for a method for preparing nilotinib intermediate. The patent, titled "Method for preparing nilotinib intermediate," discloses a process for synthesizing 3-(4-methyl-1H-imidazol-1-yl)-5-trifluoromethyl phenylamine. The method involves using trifluorotoluene as an initial material and includes steps such as nitration, bromization, condensation, and reduction. Compared to prior art, this preparation method boasts a relatively high yield, easy availability of raw materials, a concise process, and minimal side reactions. This innovation promotes the development of economic technology for bulk drug production.

Career Highlights

Deli Zeng has worked with Suzhou Lixin Pharmaceutical Co., Ltd., where he has applied his expertise in pharmaceutical development. His career reflects a commitment to advancing drug synthesis techniques that are both effective and practical for industrial use.

Collaborations

Deli Zeng has collaborated with notable professionals in his field, including Xuenong Xu and Liang Shu. These collaborations have likely contributed to the success of his innovative projects and patents.

Conclusion

Deli Zeng is a prominent figure in pharmaceutical innovation, with a focus on developing efficient methods for drug synthesis. His contributions, particularly in the preparation of nilotinib intermediates, highlight his role in advancing pharmaceutical chemistry.